| First Author | Sahún-Español Á | Year | 2022 |
| Journal | Sci Rep | Volume | 12 |
| Issue | 1 | Pages | 5938 |
| PubMed ID | 35396524 | Mgi Jnum | J:338296 |
| Mgi Id | MGI:7262448 | Doi | 10.1038/s41598-022-09757-x |
| Citation | Sahun-Espanol A, et al. (2022) p38 MAPK priming boosts VSMC proliferation and arteriogenesis by promoting PGC1alpha-dependent mitochondrial dynamics. Sci Rep 12(1):5938 |
| abstractText | Vascular smooth muscle cell (VSMC) proliferation is essential for arteriogenesis to restore blood flow after artery occlusion, but the mechanisms underlying this response remain unclear. Based on our previous findings showing increased VSMC proliferation in the neonatal aorta of mice lacking the protease MT4-MMP, we aimed at discovering new players in this process. We demonstrate that MT4-MMP absence boosted VSMC proliferation in vitro in response to PDGF-BB in a cell-autonomous manner through enhanced p38 MAPK activity. Increased phospho-p38 in basal MT4-MMP-null VSMCs augmented the rate of mitochondrial degradation by promoting mitochondrial morphological changes through the co-activator PGC1alpha as demonstrated in PGC1alpha(-/-) VSMCs. We tested the in vivo implications of this pathway in a novel conditional mouse line for selective MT4-MMP deletion in VSMCs and in mice pre-treated with the p38 MAPK activator anisomycin. Priming of p38 MAPK activity in vivo by the absence of the protease MT4-MMP or by anisomycin treatment led to enhanced arteriogenesis and improved flow recovery after femoral artery occlusion. These findings may open new therapeutic opportunities for peripheral vascular diseases. |
